+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
INSECTICID

Insecticides (India) Share Price

 

 

Insecticides (India) live price: ₹675. It opened at ₹687 vs previous close ₹689; intraday high/low: ₹694/₹670. The 50 & 200 DMA stand at ₹701.17/₹699.03.

Insecticides (India) Performance

  • Today's Low
  • ₹670
  • Today's High
  • ₹694
  • 52 Week Low
  • ₹519
  • 52 Week High
  • ₹1,098
  • Open Price₹687
  • Previous Close₹689
  • Volume18,935
  • 50 DMA₹701.17
  • 100 DMA₹689.56
  • 200 DMA₹699.03

Insecticides (India) Chart

Investment Returns

  • Over 1 Month -9.87%
  • Over 3 Month + 17.42%
  • Over 6 Month -4.34%
  • Over 1 Year -25.76%

Smart Investing Starts Here Start SIP with Insecticides (India) for Steady Growth!

Invest Now

Insecticides (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 14.1
  • PEG Ratio
  • -8.5
  • Market Cap Cr
  • 1,964
  • P/B Ratio
  • 1.6
  • Average True Range
  • 22.34
  • EPS
  • 47.91
  • Dividend Yield
  • 0.3
  • MACD Signal
  • 0.6
  • RSI
  • 40.25
  • MFI
  • 35.75

Latest Stock News Updates

Q4FY26 & FY26 Result Announced for Insecticides (India) Ltd.

Agrochemicals company Insecticides (India) announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenue from Operations: Consolidated revenue for Q4FY26 was Rs. 42,625.96 lakh, a QoQ increase of 10.74% from Rs. 38,491.62 lakh and a YoY increase of 18.76% from Rs. 35,892.05 lakh. For the full year FY26, consolidated revenue reached Rs. 2,14,000.98 lakh compared to Rs. 1,99,994.96 lakh in FY25. Total Income: Consolidated total income for FY26 stood at Rs. 2,15,171.86 lakh compared to Rs. 2,00,694.51 lakh in FY25. Profit Before Tax (PBT): For the full year FY26, consolidated PBT was Rs. 18,667.93 lakh compared to Rs. 19,276.99 lakh in FY25. Net Profit: Consolidated net profit for FY26 was Rs. 13,941.10 lakh, compared to Rs. 14,201.86 lakh in FY25. Total Comprehensive Income: For the full year FY26, consolidated total comprehensive income was Rs. 14,163.75 lakh compared to Rs. 14,067.69 lakh in FY25. Standalone Financial Highlights: Revenue from Operations: For Q4FY26, the company reported revenue of Rs. 42,795.60 lakh, representing a QoQ increase of 11.57% compared to Rs. 38,356.38 lakh in Q3FY26 and a YoY increase of 19.16% compared to Rs. 35,914.51 lakh in Q4FY25. For the full year FY26, revenue stood at Rs. 2,14,414.11 lakh compared to Rs. 2,00,226.58 lakh in FY25, a growth of 7.09%. Total Income: Total income for Q4FY26 was Rs. 43,275.89 lakh, up 12.56% QoQ from Rs. 38,445.26 lakh and up 19.52% YoY from Rs. 36,208.05 lakh. For the full year FY26, total income reached Rs. 2,15,625.23 lakh against Rs. 2,00,949.16 lakh in FY25. Profit Before Tax (PBT): The PBT for Q4FY26 stood at Rs. 1,870.24 lakh, showing a QoQ growth of 52.87% over Rs. 1,223.41 lakh in Q3FY26, but a YoY decline of 15.95% compared to Rs. 2,225.13 lakh in Q4FY25. For FY26, PBT was Rs. 18,197.70 lakh compared to Rs. 19,028.49 lakh in FY25. Net Profit: Net profit for Q4FY26 was Rs. 1,436.37 lakh, a QoQ increase of 62.43% from Rs. 884.30 lakh and a YoY increase of 2.42% from Rs. 1,402.49 lakh. For the full year FY26, net profit was Rs. 13,581.74 lakh compared to Rs. 13,976.56 lakh in FY25. Total Comprehensive Income: For the full year FY26, total comprehensive income was Rs. 13,803.30 lakh compared to Rs. 13,848.59 lakh in FY25. Business Highlights: Segment Performance: The company operates in a single business segment, "Agro-Chemicals," which comprises Technical and Formulation activities. New Employee Stock Purchase Scheme: The Board approved the "IIL ESPS Scheme 2026," covering an aggregate number of up to 2,00,000 equity shares of face value Rs. 10 each. The scheme is subject to shareholder approval at the upcoming 29th Annual General Meeting. Board and Management Changes: The Board accepted the resignation of Mrs. Nikunj Aggarwal as Whole Time Director with effect from May 28, 2026. Mr. Sanskar Aggarwal was appointed as Whole Time Director (Additional) for a five-year term effective from May 28, 2026, to May 27, 2031. Mr. Atul Kumar was appointed as Vice President - Sales (North). Subsidiary Liquidation: The company completed the dissolution/liquidation of its wholly owned subsidiary, IIL Overseas DMCC, Dubai, which was approved by the registrar on September 19, 2025. Internal Auditor Appointment: M/s. T Jain & Associates, Chartered Accountants, were appointed as Internal Auditors for a five-year period from April 01, 2026, to March 31, 2031. Annual General Meeting: The 29th AGM is scheduled to be held on Wednesday, August 12, 2026. Commenting on the results and performance, Rajesh Kumar Aggarwal, MD of Insecticides (India). said: “Insecticides (India) Limited delivered a steady performance during the year, supported by healthy growth momentum and stable margins, despite a challenging operating environment marked by erratic rainfall, restricted field activities, and global disruptions. The Company continued to strengthen its innovation-led product portfolio through successful launches in collaboration with leading global partners. Key launches included Altair with Nissan Chemical Corporation and Sparcle & Granuvia with Corteva Agriscience, offering reliable, easy-to-use, and next-generation crop solutions to Indian farmers. To further enhance market reach and distribution depth, we introduced B2C products under Kaeros Research Limited, wholly owned subsidiary of the Company. Going forward, IIL remains focused on strengthening its product pipeline, expanding strategic collaborations, enhancing organizational capabilities, premiumizing its brand equity, deepening dealer and farmer engagement, and driving innovative marketing initiatives/ Amid global uncertainties, the Company remains agile and committed to building a stronger, more resilient, and future-ready organization. Result PDF

Q3FY26 Quarterly Result Announced for Insecticides (India) Ltd.

Agrochemicals company Insecticides (India) announced Q3FY26 results Revenue: Rs 38,491.62 crore against Rs 35,770.47 crore during Q3FY25, change 8%. PBT: Rs 1,430.26 crore against Rs 2,228.16 crore during Q3FY25, change -36%. PAT: Rs 1,048.82 crore against Rs 1,736.5 crore during Q3FY25, change -40%. EPS: 3.6 for Q3FY26. Result PDF

Agrispective| EP 05| Roots, routes, and revenues: Can India stay ahead in the global agrochemical game?

India has huge scope as a manufacturing country with strong domestic demand and significant export potential, and the growing demand for food means agrochemicals are in high demand, says Rajesh Aggarwal, MD, Insecticides (India) Ltd

Insecticides (India) Financials

Insecticides (India) Technicals

EMA & SMA

Current Price
₹675.00
-13.9 (-2.02%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹711.30
  • 50 Day
  • ₹701.20
  • 100 Day
  • ₹689.60
  • 200 Day
  • ₹699.00

Resistance and Support

698.45 Pivot Speed
  • R3 743.85
  • R2 731.90
  • R1 710.40
  • S1 676.95
  • S2 665.00
  • S3 643.50

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Insecticides (India) Ltd. is a leading manufacturer of agrochemicals, specializing in insecticides, herbicides, and fungicides. The company focuses on providing high-quality, innovative solutions for pest control in agriculture, contributing to sustainable farming practices and enhanced crop protection.

Insecticides India has an operating revenue of Rs. 2,140.01 Cr. on a trailing 12-month basis. An annual revenue growth of 7% is good, Pre-tax margin of 9% is okay, ROE of 11% is good. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 40 which is a POOR score indicating inconsistency in earnings, a RS Rating of 48 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 136 indicates it belongs to a poor industry group of Chemicals-Agricultural and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Insecticides (India) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-28 Audited Results
2026-01-30 Quarterly Results, Dividend & Others To consider other business matters. per share(30%)Final Dividend
2025-11-12 Quarterly Results & Others To consider other business matters. per share(30%)Final Dividend
2025-08-13 Quarterly Results
2025-05-28 Audited Results & Others To consider other business matters. per share(30%)Final Dividend
Date Purpose Remarks
2026-02-06 INTERIM Rs.2.00 per share(20%)Interim Dividend
2024-08-23 INTERIM Rs.2.00 per share(20%)Interim Dividend
2023-11-10 INTERIM Rs.3.00 per share(30%)Interim Dividend
2023-02-24 INTERIM Rs.3.00 per share(30%)Interim Dividend
View Insecticides (India) Dividend History Arrow
Date Purpose Remarks
2022-10-03 Bonus Rs.0.00 issue in the ratio of 1:2 of Rs. 10/-.

Insecticides (India) Shareholding Pattern

72.3%
8.93%
4.5%
11.04%
3.23%

Insecticides (India) FAQs

Insecticides (India) share price is ₹675 As on 23 June, 2026 | 15:22

The Market Cap of Insecticides (India) is ₹1964.1 Cr As on 23 June, 2026 | 15:22

The P/E ratio of Insecticides (India) is 14.1 As on 23 June, 2026 | 15:22

The PB ratio of Insecticides (India) is 1.6 As on 23 June, 2026 | 15:22

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23